Clinical trial
Generalizability of Unsupervised Therapy After Stroke in the Home Setting With a Hand Rehabilitation Device (ReHandyBot): a Multicentric, Exploratory Study
NCT07674238 is registered in ClinicalTrials.gov with Swiss Federal Institute of Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Generalizability of Unsupervised Therapy After Stroke in the Home Setting With a Hand Rehabilitation Device (ReHandyBot): a Multicentric, Exploratory Study
- Lead sponsor
- Swiss Federal Institute of Technology
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- August 30, 2028
- Enrollment
- 40 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.